EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

IDNA

iShares Genomics Immunology and Healthcare ETF

NYSE ARCAETF
$33.58
+1.54%today

No SEC filings for this security

iShares Genomics Immunology and Healthcare ETF is a foreign or OTC-listed security (NYSE ARCA) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$20.43 – $33.58
20.4352-week33.58
Volume
152K
1Y return
+62.61%
Beta
0.00

Price · 1Y

$33.58▲ +62.61%
over 1Y
L $20.25EODHDH $33.58

Recent news

market news →
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?Bullish
finance.yahoo.com· 2026-06-23
We now live in a world of rolling bubbles – analystBullish
seekingalpha.com· 2026-06-10
3 ETFs For the Coming Genomics RevolutionBullish
finance.yahoo.com· 2026-06-07
Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price SkyrocketsBullish
finance.yahoo.com· 2026-04-08
Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share PriceBullish
finance.yahoo.com· 2026-03-26
AI Scare Back in the Market: ETFs That Stayed SteadyBullish
finance.yahoo.com· 2026-02-24
Here's Why Biotech ETFs Are Rallying HardBullish
finance.yahoo.com· 2026-01-09
LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocksBullish
seekingalpha.com· 2025-11-21

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.